首页> 美国卫生研究院文献>Filaria Journal >Developing novel anthelmintics from plant cysteine proteinases
【2h】

Developing novel anthelmintics from plant cysteine proteinases

机译:从植物半胱氨酸蛋白酶开发新型驱虫药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intestinal helminth infections of livestock and humans are predominantly controlled by treatment with three classes of synthetic drugs, but some livestock nematodes have now developed resistance to all three classes and there are signs that human hookworms are becoming less responsive to the two classes (benzimidazoles and the nicotinic acetylcholine agonists) that are licensed for treatment of humans. New anthelmintics are urgently needed, and whilst development of new synthetic drugs is ongoing, it is slow and there are no signs yet that novel compounds operating through different modes of action, will be available on the market in the current decade. The development of naturally-occurring compounds as medicines for human use and for treatment of animals is fraught with problems. In this paper we review the current status of cysteine proteinases from fruits and protective plant latices as novel anthelmintics, we consider some of the problems inherent in taking laboratory findings and those derived from folk-medicine to the market and we suggest that there is a wealth of new compounds still to be discovered that could be harvested to benefit humans and livestock.
机译:牲畜和人的肠道蠕虫感染主要通过三类合成药物的治疗来控制,但是一些家畜线虫现已对这三类产生抗药性,并且有迹象表明,人钩虫对这两种类的反应性减弱(苯并咪唑和烟碱型乙酰胆碱激动剂)。迫切需要新的驱虫药,尽管新合成药物的开发正在进行中,但进展缓慢,并且尚无迹象表明在当前的十年中将通过不同的作用方式发挥作用的新型化合物投放市场。天然存在的化合物作为人类使用和动物治疗药物的开发充满了问题。在本文中,我们回顾了水果和保护性植物胶乳中半胱氨酸蛋白酶作为新型驱虫药的现状,我们考虑了将化验结果和民间医学推向市场所固有的一些问题,并建议有很多尚待发现的一些新化合物可以被收获,以造福人类和牲畜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号